Lupus drug trial pulled before it even started
NCT ID NCT06456567
First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This study was designed to test a drug called telitacicept for people with moderate-to-severe systemic lupus erythematosus (SLE), an autoimmune disease. The goal was to see if the drug could reduce lupus symptoms and allow lower steroid use. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hemet site
Hemet, California, 92543, United States
-
Menifee site
Menifee, California, 92586, United States
-
Rockford site
Rockford, Illinois, 61114, United States
-
Stafford site
Stafford, Texas, 77477, United States
Conditions
Explore the condition pages connected to this study.